Advertisement
New Zealand markets closed

  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     

  • NZD/USD

    0.5956
    +0.0007 (+0.11%)
     

  • NZD/EUR

    0.5544
    +0.0004 (+0.08%)
     

  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     

  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     

  • OIL

    83.95
    +0.38 (+0.45%)
     

  • GOLD

    2,360.50
    +18.00 (+0.77%)
     

  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     

  • FTSE

    8,114.50
    +35.64 (+0.44%)
     

  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     

  • DAX

    18,045.07
    +127.79 (+0.71%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • NZD/JPY

    93.2980
    +0.8020 (+0.87%)
     

Looking for Passive Income at a Decent Price? Buy These 2 Stocks

Alex Carchidi, The Motley Fool
·5-min read
Looking for Passive Income at a Decent Price? Buy These 2 Stocks

Many investors would love to buy passive income stocks with a high dividend yield, a sustainable level of earnings coverage of the dividend, and a cheap valuation. For instance, Zoloft, Xanax, Lyrica, Viagra, and Lipitor are just a few of the older household-name drug brands that Viatris (NASDAQ: VTRS) counts in its portfolio of generic medicines, and while none are new medicines, they're each indispensable to this day. Viatris' forward dividend yield is presently above 5.2%, which is on the high side compared to the market's average yield of around 1.6%.

Continue reading